New York City has made permanent a program that compensates drug users up to $10 per day for returning used syringes, establishing it through Mayor Zohran Mamdani's first city budget with $3 million in dedicated funding. The Community Syringe Redemption Program was quietly embedded in the city's $126 billion spending plan following its pilot phase launch in March 2025.
The program pays participants 20 cents per returned syringe, with a daily cap of 50 syringes maximum. Eight redemption sites operate across the five boroughs—five locations in the Bronx and one each in Brooklyn, Manhattan, and Queens—where enrolled participants can drop off used needles during scheduled collection hours. The initiative is administered by Addiction Response Resources, a nonprofit that runs similar programs in other cities under an $11.1 million contract extending through the end of next year.
What the Left Is Saying
City health officials defended the program as a public health measure designed to reduce dangerous syringe litter in neighborhoods that frequently report discarded needles. Health Department spokesperson Rachel Vick said the initiative helps residents live in communities free of syringe litter while safely disposing of medical waste and connecting people in need with nearby care services.
Bronx Democratic Councilman Oswald Feliz credited the effort for removing discarded syringes from public spaces, acknowledging its effectiveness in cleaning up neighborhoods. The original legislation backing the program passed through progressive City Council members in 2022 before advancing to pilot status.
Health officials have emphasized that improperly discarded syringes pose risks of needlestick injuries and disease transmission, arguing that incentivizing returns reduces these hazards while creating pathways to treatment for participants who interact with program staff at redemption sites.
What the Right Is Saying
Queens Republican Councilwoman Joann Ariola argued that opioid settlement money funding the program should instead direct all resources toward addiction treatment services. She characterized the initiative as putting money in the pockets of addicts rather than helping them overcome addiction, calling it a misuse of funds meant to address the opioid crisis.
Critics contend that $189 million in settlement funds received from major opioid manufacturers and distributors could be better deployed toward substance abuse treatment programs, rehabilitation facilities, and prevention efforts. The concern centers on whether compensating users for syringes addresses root causes of addiction or merely manages its symptoms.
Some community advocates have raised concerns about program design, with Ariola warning that the structure may not sufficiently prioritize recovery outcomes over needle collection metrics. They argue that direct treatment funding would produce more meaningful long-term results for individuals struggling with substance use disorders.
What the Numbers Show
The Health Department reports the program has collected more than 2.3 million used syringes since its launch approximately 16 months ago in March 2025. During its first full year of operation, the city paid out approximately $292,000 to more than 1,700 participants who returned needles through the redemption system.
Sanitation Department data shows workers have collected 26,229 discarded needles so far this calendar year, compared to 64,560 during the same period in 2025—a significant reduction that officials attribute partly to increased community participation in safe disposal programs. The city allocated $3 million in the current budget to continue the program beyond its pilot phase.
The program's $11.1 million contract with Addiction Response Resources extends through December 2027 and covers operational costs including staffing, site management, participant compensation, and administrative expenses. Participants can earn a maximum of $10 daily by returning up to 50 syringes per visit to designated redemption locations.
The Bottom Line
NYC has permanently established funding for the syringe redemption program as part of its budget structure, meaning it will continue operating without requiring additional legislative approval unless officials choose to modify or eliminate it. Opponents may seek to redirect opioid settlement funds toward treatment programs through future budget negotiations or council legislation.
The program's permanence contrasts with its pilot status, which required periodic reauthorization. With $3 million dedicated in the current spending plan and a contract extending into 2027, city officials have committed to the initiative for at least the near term regardless of ongoing debates about whether settlement funds represent appropriate financing for harm reduction approaches versus treatment-focused alternatives.